Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey E Rubnitz

Showing results (1-10 of 178) with videos related to

Pageof 18
Sort By:
Current Treatment Options in Oncology|May 29, 2008
Childhood acute myeloid leukemiaJeffrey E Rubnitz
Blood|May 9, 2012
How I treat pediatric acute myeloid leukemiaJeffrey E Rubnitz
Paediatric Drugs|October 28, 2016
Current Management of Childhood Acute Myeloid LeukemiaJeffrey E Rubnitz
Expert Review of Hematology|May 30, 2014
Recent research and future prospects for gemtuzumab ozogamicin: could it make a comeback?Carol O'Hear, Jeffrey E Rubnitz
British Journal of Haematology|September 13, 2012
Childhood acute myeloid leukaemiaJeffrey E Rubnitz, Hiroto Inaba
Current Opinion in Hematology|June 4, 2002
TEL/AML1-positive pediatric leukemia: prognostic significance and therapeutic approachesMignon L Loh, Jeffrey E Rubnitz
Discovery Medicine|May 16, 2015
New approaches for the immunotherapy of acute myeloid leukemiaTerrence L Geiger, Jeffrey E Rubnitz
Cancer Treatment Reviews|March 14, 2003
Recent advances in the treatment and understanding of childhood acute lymphoblastic leukaemiaJeffrey E Rubnitz, Ching-Hon Pui
Blood|June 11, 2021
How I treat pediatric acute myeloid leukemiaJeffrey E Rubnitz, Gertjan J L Kaspers
The Pediatric Infectious Disease Journal|January 20, 2011
Isolated nasal septum necrosis caused by Aspergillus flavus in an immunocompromised childFouzia Naeem, Jeffrey E Rubnitz, Hana Hakim
Pageof 18

Showing results (1-10 of 178) with videos related to

Sort By:
Pageof 18
Current Treatment Options in Oncology|May 29, 2008
Childhood acute myeloid leukemiaJeffrey E Rubnitz
Blood|May 9, 2012
How I treat pediatric acute myeloid leukemiaJeffrey E Rubnitz
Paediatric Drugs|October 28, 2016
Current Management of Childhood Acute Myeloid LeukemiaJeffrey E Rubnitz
Expert Review of Hematology|May 30, 2014
Recent research and future prospects for gemtuzumab ozogamicin: could it make a comeback?Carol O'Hear, Jeffrey E Rubnitz
British Journal of Haematology|September 13, 2012
Childhood acute myeloid leukaemiaJeffrey E Rubnitz, Hiroto Inaba
Current Opinion in Hematology|June 4, 2002
TEL/AML1-positive pediatric leukemia: prognostic significance and therapeutic approachesMignon L Loh, Jeffrey E Rubnitz
Discovery Medicine|May 16, 2015
New approaches for the immunotherapy of acute myeloid leukemiaTerrence L Geiger, Jeffrey E Rubnitz
Cancer Treatment Reviews|March 14, 2003
Recent advances in the treatment and understanding of childhood acute lymphoblastic leukaemiaJeffrey E Rubnitz, Ching-Hon Pui
Blood|June 11, 2021
How I treat pediatric acute myeloid leukemiaJeffrey E Rubnitz, Gertjan J L Kaspers
The Pediatric Infectious Disease Journal|January 20, 2011
Isolated nasal septum necrosis caused by Aspergillus flavus in an immunocompromised childFouzia Naeem, Jeffrey E Rubnitz, Hana Hakim
Pageof 18